Numab Therapeutics AG Company Contacts

Numab Therapeutics AG

http://www.numab.com
Numab Therapeutics is developing multi-specific antibody-based immunotherapies for inflammation and cancer. Reproducible plug-and-play therapeutic design process using proprietary platforms λ-Cap™ and MATCH™ puts Numab in a unique position to overcome historical drug discovery barriers and build a pipeline of first-in-class... Read More
Contacts

Country

Switzerland

City

Horgen

Headquarters

Horgen, CH

Profile

Founded

2011

Industry

Biotechnology Research

Size

51 - 200

Funding

Total Rounds

3

Last Round

Sun Dec 04 2022

Last Round Series

Series C

Last Round Raised

No Data